Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,791,784
+$1,982,790 QoQ
Shares Held
115,363
+134.6% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#69
of 193 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. GLUE ranks #60 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in GLUE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,791,784 | 115,363 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $808,994 | 49,179 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,347,484 | 149,712 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $121,512 | 26,188 | Shares | Sole | 2025-05-14 | |
| 2023-09-30 | $122,897 | 25,657 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $100,845 | 14,722 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $169,237 | 21,725 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $128,867 | 16,934 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $339,872 | 41,600 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||